Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects Over 13 Million Americans Each Year: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
Via Get News
Exposures Product Safety
Tickers NRXP
DENTSPLY SIRONA Inc. (XRAY) Investors: January 27, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
Via PRLog
Exposures Product Safety
Tickers JPM
Axsome Therapeutics Stock Tumbles As Alzheimer's Studies Reveal Mixed Results: Retail Sentiment Remains Bullish
Via Stocktwits
Exposures Product Safety
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
Via PRLog
Topics Death
Exposures Death Product Safety
Class Action Announcement (APLT): A Securities Fraud Class Action Lawsuit Was Filed Against Applied Therapeutics, Inc.
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc. (XRAY)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Common Stock of Applied Therapeutics, Inc. (NASDAQ: APLT)
Via NewMediaWire
Exposures Product Safety
Tickers APLT
Bristol Myers Squibb Stock In Focus After FDA Approves Cancer Drug: Retail Sentiment Brightens
Via Stocktwits
Exposures Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R)
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Kessler Topaz Meltzer & Check, LLP Reminds APLT Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc. (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against DENTSPLY SIRONA Inc. (XRAY)
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Clene Inc. (NASDAQ: CLNN) Improves Cash Position and Runway with New Debt Facility for CNM-Au8(R) Data Collection to Support Accelerated Approval Application
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
APLT DEADLINE FOR LEADERSHIP is February 18, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
Via Newsfile
Exposures Product Safety
Tickers ELTP
Global Times: Chinese-built hydropower station lights up homes of remote Lao village, dreams of prosperity
Via Get News
Topics Product Recall
Exposures Legal Product Safety
APPLIED THERAPEUTICS DEADLINE FOR LEADERSHIP is February 18, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc. (XRAY)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Eli Lilly Stock Is Rising Monday: What's Going On?
Via Benzinga
Exposures Product Safety
Tickers LLY
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
Via Benzinga
Exposures Product Safety
Tickers VRTX
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awaits FDA Decision on TNX-102 SL for Fibromyalgia
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Does This News From the FDA Make Eli Lilly a Buy for 2025?
Via The Motley Fool
Exposures Product Safety
Tickers LLY
Global Times: Chinese-built hydropower station lights up homes of remote Lao village, dreams of prosperity
Via Prodigy
Topics Product Recall
Exposures Legal Product Safety
Will The Falling Hims & Hers Stock Price Recover In 2025?
Via Talk Markets
Topics Stocks / Equities
Exposures Product Safety
Tickers HIMS
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Via Benzinga
Exposures Product Safety
Tickers LLY NVO
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Vertex Wins An Early Approval; Why It Might Not Move Vertex's Beleaguered Stock
Via Investor's Business Daily
Exposures Product Safety
Tickers VRTX
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.